西南国防医药
西南國防醫藥
서남국방의약
MEDICAL JOURNAL OF NATIONAL DEFENDING FORCES IN SOUTHWEST CHINA
2014年
5期
481-483
,共3页
何琳琳%杜文华%李毅%王校斌
何琳琳%杜文華%李毅%王校斌
하림림%두문화%리의%왕교빈
阿托伐他汀%脑梗死%神经功能%复发%剂量
阿託伐他汀%腦梗死%神經功能%複髮%劑量
아탁벌타정%뇌경사%신경공능%복발%제량
atorvastatin%acute cerebral infarction%neurological function%recurrence rate%dose
目的:观察大剂量阿托伐他汀对急性脑梗死( ACI)患者血脂、神经功能恢复情况及1年复发率的影响。方法120例发病72 h内入院的ACI患者随机分为2组,口服阿托伐他汀20 mg/d组(对照组)和40 mg/d组(治疗组)各60例,观察治疗前和治疗4 w后患者血脂水平,用美国国立卫生研究所脑卒中评分( NIHSS)评定患者神经功能缺损程度,观察治疗1年后患者生活能力Barthel指数( BI)、脑缺血事件复发率。结果治疗4 w后,两组血脂水平、神经功能缺损程度较治疗前明显好转(P<0.01),但治疗组均明显优于对照组(P<0.01)。1年后生活能力BI指数、复发率,两组均较治疗前明显改善(P<0.01),治疗组改善明显优于对照组(P<0.05)。结论大剂量阿托伐他汀治疗ACI,可更有效地降低血脂水平,促进神经功能恢复,提高患者的生活能力,并降低脑缺血事件复发率。
目的:觀察大劑量阿託伐他汀對急性腦梗死( ACI)患者血脂、神經功能恢複情況及1年複髮率的影響。方法120例髮病72 h內入院的ACI患者隨機分為2組,口服阿託伐他汀20 mg/d組(對照組)和40 mg/d組(治療組)各60例,觀察治療前和治療4 w後患者血脂水平,用美國國立衛生研究所腦卒中評分( NIHSS)評定患者神經功能缺損程度,觀察治療1年後患者生活能力Barthel指數( BI)、腦缺血事件複髮率。結果治療4 w後,兩組血脂水平、神經功能缺損程度較治療前明顯好轉(P<0.01),但治療組均明顯優于對照組(P<0.01)。1年後生活能力BI指數、複髮率,兩組均較治療前明顯改善(P<0.01),治療組改善明顯優于對照組(P<0.05)。結論大劑量阿託伐他汀治療ACI,可更有效地降低血脂水平,促進神經功能恢複,提高患者的生活能力,併降低腦缺血事件複髮率。
목적:관찰대제량아탁벌타정대급성뇌경사( ACI)환자혈지、신경공능회복정황급1년복발솔적영향。방법120례발병72 h내입원적ACI환자수궤분위2조,구복아탁벌타정20 mg/d조(대조조)화40 mg/d조(치료조)각60례,관찰치료전화치료4 w후환자혈지수평,용미국국립위생연구소뇌졸중평분( NIHSS)평정환자신경공능결손정도,관찰치료1년후환자생활능력Barthel지수( BI)、뇌결혈사건복발솔。결과치료4 w후,량조혈지수평、신경공능결손정도교치료전명현호전(P<0.01),단치료조균명현우우대조조(P<0.01)。1년후생활능력BI지수、복발솔,량조균교치료전명현개선(P<0.01),치료조개선명현우우대조조(P<0.05)。결론대제량아탁벌타정치료ACI,가경유효지강저혈지수평,촉진신경공능회복,제고환자적생활능력,병강저뇌결혈사건복발솔。
Objective To observe the efficacy of high-dose atorvastatin in nervous functional rehabilitation in patients with acute cerebral infarction ( ACI) and 1-year recurrence rate .Methods 120 cases suffered from ACI in 72 h were randomly divided into 2 groups:conventional-dose atorvastatin treatment group(control group,20 mg/d)and high-dose atorvastatin treatment group(treatment group,40 mg/d),60 cases in each group.Before and after 4 weeks treatment,their blood lipid level was measured and the degree of neurological deficits was evaluated with the U .S.National Institutes of Health Stroke Score ( NIHSS ) .The Barthel index ( BI ) and cerebral ischemic event recurrence rate were observed after one year .Results The level of blood lipid and the degree of neurological deficits in both groups were significantly better after 4 weeks treatment than those before treatment (P<0.01);BI and the recurrence rate in both groups after one year were significantly better than those before treatment (P<0.01).The therapeutic effect was better in the treatment group than that in the control group (P<0.05).Conclusions High-dose atorvastatin has a good effect on ACI and can reduce 1-year recurrence rate .